BAFI-1070 Nanosonics Limited Case Study Sample

• Subject Code : BAFI-1070
• University : RMIT University My Assignment Services is not sponsored or endorsed by this college or university.
• Subject Name : Accounting and Finance

Financial Statement Analysis

Conclusion on Nanosonics Limited

Nanosonics Limited is an Australian company that focuses on automated disinfection technology development. The main operations of the company include the manufacture and sale of trophon ultrasonic disinfectant samples and accessory equipment, as well as the research, production and marketing of drugs and related technologies for infection, control and detoxification. The company's automated electron paramagnetic resonance (EPR) disinfecting tool offers therapeutic approaches in the field of disinfection of ultrasonic probes. Trophone is a way to the cross-contamination and the spread of acquired healthcare acquired infections (HAIs). Its products from Trophone 2 include AcuTrace technology which allows digital records to be stored and provides the workflow for high-level ultrasound testing. Nano nebulizers, chemical indicator trophies, actuator card trophies and printer trophies are all part of electronic equipment.

It has been observed that Nanosonic is a growing firm since last five years of its operations. Firm has remarkable growth and significant raises in its financial measures like revenues profits, basic earnings, salaries of employees and market share in automatic disinfection technology firms working in Australia. Company have sharp growth in revenues from 2015 to annual results of December 2019, as revenues of the firm raised from 22214 thousand dollars to 84324 thousand dollars. As it has almost 100% growth of revenues from 2015 to 2016. Company’s profit and loss statement was negative in 2015 with loss of 5465 thousand dollars but it has remarkable recovery in 2016 with positive sign of profit valued 136 thousand and 13852 thousand dollars in 2017. Earnings per share has also same line growth from 2015 to 2019 with values of -2.03 in 2015 and 4.54 in 2019. Gross profit has also been doubled from 2016 to 2019 valued 32170 thousand to 62820 thousand at the end of 2019 (Annual report 2019).

There was dump performance observations in 2018 with down fall in revenues and profits, it was shocking for the firm but again appreciating, they recovered it track in 2019.

According to the forecast, the FY18 results brought about a shift of previous sales and reduction of EPR Trophone inventory with the resulting Trophone regulatory approval and some customers delayed purchases until a new Trophone model was introduced. The selling also reflects a rise in sales models with different income profiles, including in the UK's MES, where there are no permitted capital earnings for more trophy units.

Share price of the firm has been raised from 1.82 dollars in 2015 to 6.95 in 2020 and still growing trend on track of the firm.

Nanosonics, the development company responsible for hospital infection control, has seen product sales rise in the last decade, but, going towards limitations of the operations, the organization will not stand up to widespread contamination by the Covid-19 system. Its recommended to find out alternate sources for increasing revenue due to unlimited spam of Covid-19.

Traceability, enforcement, cleaning and disinfection, storage, safety of the environment and digital solutions have become the key five areas of product investment for the achievements of emerging Medtech Nanosonics. But here social distances are another reason to obtain past track of results, operations are limited in all aspect of the business. Its recommended to produce3 more secure and safe equipment to avoid the risk of Covid-19. Any development should have good results with a minor partiality in a low-growth climate between past developments.

According to some high-performance fund managers * the difference between best returns and good returns leads to companies with greater efficiency than the package and a desire to avoid volatility as it explodes. During the post-mortem reporting season, a significant number of organizations are reflecting on the problems that people face in a globally sluggish market and not meet standards. However, there are companies which give and will continue to do good in our opinion. Business need more care and techniques for unlimited future risk of social distancing so company need to keep all operative techniques on first hand to meet worldwide danger of virus spread. As only healthcare sector is more active in recent two months of Covid-19 inception. This danger could be converted to an opportunity for the organization as there is no prominent success in controlling this virus. For healthcare sector there is vast ground to perform and to be the best in overall world these days.

References for Nanosonics Limited

Annual report 2019

Annual report 2018

Remember, at the center of any academic work, lies clarity and evidence. Should you need further assistance, do look up to our Accounting and Finance Assignment Help